Effects of Agent-assisted, LLM-assisted and Traditional Workflows on Diagnosis and Management Planning at Admission
1 other identifier
interventional
180
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether AI-assisted workflows improve physicians' admission diagnosis and management planning performance on standardized simulated inpatient cases, among practicing internal medicine and surgery physicians across all seniority levels and across three tiers of the Chinese healthcare system. The main questions it aims to answer are:
- Does the Agent-assisted workflow yield better structured admission diagnosis and management planning scores than standalone LLM assistance?
- Does the Agent-assisted workflow outperform the traditional workflow without AI tools? Researchers will compare three parallel groups (traditional workflow group, LLM-assisted group, Agent-assisted group) to determine whether the Agent tool can improve diagnostic accuracy and efficiency. The goal of this clinical trial is to evaluate whether AI-assisted workflows improve physicians' admission diagnosis and management planning performance on standardized simulated inpatient cases, among practicing internal medicine and surgery physicians across all seniority levels and across three tiers of the Chinese healthcare system. The main questions it aims to answer are:
- Does the Agent-assisted workflow yield better diagnosis and management planning scores than the LLM-assisted workflow?
- Does the Agent-assisted workflow yield better diagnosis and management planning scores than the conventional workflow without AI assistance? Researchers will compare three parallel groups (traditional workflow group, LLM-assisted group, Agent-assisted group) to determine whether the agent tool can improve diagnostic and management planning performance and efficiency. Participants will:
- Be recruited from 15 hospitals in China and participate remotely under video proctoring
- Be randomly assigned to one of the three fixed workflows, with randomization stratified by hospital tier, specialty and seniority
- Work through 6 anonymized simulated HIS admission cases and complete as many as they can.
- Submit structured answers for each case covering principal diagnosis, secondary diagnoses, differential diagnoses, diagnostic justification, next diagnostic or therapeutic steps, consultation and referral decisions, and diagnostic confidence.
- Have their operation logs and time consumption recorded automatically by the study platform.
- Complete a post-session questionnaire after submitting all cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedStudy Start
First participant enrolled
September 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
September 28, 2026
September 1, 2026
3 months
July 29, 2026
September 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Normalized Structured Score
Mean of the rescaled case scores (each case rescaled to 100), divided by the number of cases completed; range 0 to 100.
Within one-hour study
Secondary Outcomes (2)
Active Response Time per Case
Within one-hour study
Degree of Adherence to AI-Generated Recommendations
Within one-hour study
Study Arms (3)
Agent-assisted group
EXPERIMENTALLLM-assisted group
EXPERIMENTALTraditional group
ACTIVE COMPARATORInterventions
Conventional resources only: the pre-admission clinical record, conventional search engines, permitted conventional non-generative clinical information resources. No AI assistance.
Conventional resources (the pre-admission clinical record, conventional search engines, permitted conventional non-generative clinical information resources) plus an in-system Agent entry that automatically reads the full record and report images, produces a structured summary with source-text tracing, and supports multi-turn Q\&A and one-click editable drafts.
Conventional resources (the pre-admission clinical record, conventional search engines, permitted conventional non-generative clinical information resources) plus an in-system multi-turn AI dialogue entry. The AI does not automatically read the record; participants paste text or send partial screenshots.
Eligibility Criteria
You may qualify if:
- Hold a Medical Practitioner Qualification Certificate and/or Medical License, or be a recognized standardized resident physician; able to independently read electronic medical records, laboratory and imaging reports on an HIS.
- Currently engaged in clinical work in internal medicine or surgery at one of the 15 participating hospitals.
- Able to complete the case assessment in one continuous hour without breaks.
- Able to participate remotely under video proctoring, with a stable internet connection and a working camera.
- Voluntarily agree to participate and sign the informed consent form, including the declaration not to use unauthorized AI tools during the assessment.
- Have not participated in case drafting, review, rubric development, or any activity that may leak the reference standard.
You may not qualify if:
- Have previously accessed the official test cases or reference standard of this study.
- Unable to complete the training module, qualification test, or all experimental tasks.
- Have conflicts of interest, e.g. participation in developing core algorithms of the tested system.
- Unwilling to comply with remote proctoring, including keeping the camera on throughout.
- Judged unsuitable by the investigators.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310009, China
Study Officials
- STUDY CHAIR
Yuan Ding
Second Affiliated Hospital, Zhejiang University, School of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Participants and investigators cannot be masked, as the intervention is the workflow itself. Outcome assessors scoring the structured answers are blinded to group allocation; submitted answers are anonymized and stripped of workflow-identifying information before scoring.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2026
First Posted
August 12, 2026
Study Start
September 6, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
September 28, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share